Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 6/2013

01.12.2013 | Psychosocial Aspects (KK Hood, Section Editor)

Technology to Optimize Pediatric Diabetes Management and Outcomes

verfasst von: Jessica T. Markowitz, Kara R. Harrington, Lori M. B. Laffel

Erschienen in: Current Diabetes Reports | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Technology for diabetes management is rapidly developing and changing. With each new development, there are numerous factors to consider, including medical benefits, impact on quality of life, ease of use, and barriers to use. It is also important to consider the interaction between developmental stage and technology. This review considers a number of newer diabetes-related technologies and explores issues related to their use in the pediatric diabetes population (including young adults), with a focus on psychosocial factors. Areas include trend technology in blood glucose monitoring, continuous glucose monitoring, sensor-augmented insulin pumps and low glucose suspend functions, internet applications including videoconferencing, mobile applications (apps), text messaging, and online gaming.
Literatur
1.
The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef
2.
Laffel L, Volkening L, Hood K, Lochrie A, Nansel T, Anderson B, et al. Optimizing glycemic control in youth with T1DM: importance of BG monitoring and supportive family communication [Abstract]. Diabetes. 2006;55 Suppl 1:A197.
3.
Dailey G. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc. 2007;82:229–35.PubMed
4.
Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12:11–7.PubMedCrossRef
5.
Wood JR, Laffel LMB. Technology and intensive management in youth with type 1 diabetes: state of the art. Curr Diab Rep. 2007;7:104–13.PubMedCrossRef
6.
Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34:262–7. PMCID:PMC3024331.PubMedCrossRef
7.
Pfutzner A, Mitri M, Musholt PB, Sachsenheimer D, Borchert M, Yap A, et al. Clinical assessment of the accuracy of blood glucose measurement devices. Curr Med Res Opin. 2012;28:525–31.PubMedCrossRef
8.
Recupero A, Mahnke B, Pinsker JE. Emerging technology in diabetes care: the real-time diabetes monitoring system. Mil Med. 2013;178:218–21.PubMed
9.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008;10:310–21.CrossRef
10.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32:1378–83. PMCID:PMC2713649.CrossRef
11.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009;32:1947–53. PMCID:PMC2768196.
12.
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–20.PubMedCrossRef
13.
Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009;32:2245–50.PubMedCrossRef
14.
Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2006;114:63–7.PubMedCrossRef
15.
Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, et al. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2012;35:204–10. PMCID:PMC3263860.PubMedCrossRef
16.
Tsalikian E, Fox L, Weinzimer S, Buckingham B, White NH, Beck R, et al. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes. 2012;13:301–7.PubMedCrossRef
17.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010;12:679–84.CrossRef
18.
Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, et al. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med. 2011;28:1118–22.PubMedCrossRef
19.
Markowitz JT, Pratt K, Aggarwal J, Volkening LK, Laffel LM. Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth. Diabetes Technol Ther. 2012;14:523–6. PMCID:PMC3359621.PubMedCrossRef
20.
Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA. Test manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
21.
Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, et al. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes. 2012;13:449–53.PubMedCrossRef
22.
Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project. Diabetes Technol Ther. 2012;14:728–35.PubMedCrossRef
23.
Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012;61:2230–7. PMCID:PMC3425406.PubMedCrossRef
24.
Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM. Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care. 2013;36:222–7. PMCID:PMC3554296.PubMedCrossRef
25.
Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomized crossover trial. Lancet. 2010;375:743–51.PubMedCrossRef
26.
•• Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824–33. This group brought the study of a closed-loop system out of the lab and into a free-living environment, highlighting some novel possibilities of a system such as this.PubMedCrossRef
27.
Elleri D, Acerini CL, Allen JM, Hayes J, Pesterfield C, Wilinska ME, et al. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther. 2010;12:35–9.PubMedCrossRef
28.
van Bon AC, Brouwer TB, von Basum G, Hoekstra JB, DeVries JH. Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther. 2011;13:731–6.PubMedCrossRef
29.
• Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile. J Diabetes Sci Technol. 2013;7:562–78. The amulatory glucose profile makes diabetes data easier to understand and may help improve glycemic control in youth and adults with diabetes.PubMed
30.
Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2012;97(12):4383–89.
31.
Beck J, Lewis T, Harrison D, Sternlof S, Comp C, Copeland K. Use of the Mastery of Stress Instrument in caregivers of children newly diagnosed with type 1 diabetes: identifying a need for further intervention. Diabetes Educ. 2012;38:280–8.PubMedCrossRef
32.
Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes. 2012;13:6–11.PubMedCrossRef
33.
• Rubin RR, Peyrot M. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetes Technol Ther. 2012;14:143–51. This important study examined psychosocial issues related to the use of sensor-augmented insulin pump therapy.PubMedCrossRef
34.
Peyrot M, Rubin RR. Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabet Med. 2013;30:464–7.PubMedCrossRef
35.
Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, et al. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia. 2010;53:2487–95.PubMedCrossRef
36.
•• Ruedy KJ. The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis: diabetes research in Children Network (DirecNet) and type 1 diabetes TrialNet Study Groups. Diabetes Technol Ther. 2013;15(5). This important study examined the use of closed-loop therapy in newly diagnosed patients with T1D and it was found to be safe and effective.
37.
Buckingham B, Ruedy K, Chase HP, Weinzimer S, DiMeglio L, Russell W, et al. Does intensive metabolic control at the onset of diabetes followed by one year of sensor-augmented pump therapy improve c-peptide levels one year post diagnosis? ATTD. 2013;[Late Breaking Abstracts].
38.
Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34:2023–5. PMCID:PMC3161284.PubMedCrossRef
39.
Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011;13:1129–34.PubMedCrossRef
40.
Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14:205–9.PubMedCrossRef
41.
van Bastelaar KM, Pouwer F, Cuijpers P, Riper H, Snoek FJ. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2011;34:320–5. PMCID:PMC3024341.PubMedCrossRef
42.
Stinson J, Wilson R, Gill N, Yamada J, Holt J. A systematic review of internet-based self-management interventions for youth with health conditions. J Pediatr Psychol. 2009;34:495–510.PubMedCrossRef
43.
Harris MA, Freeman KA, Duke DC, Hirschfield B, Boston B. Skype-based family problem solving for youth with poorly controlled diabetes: relative effectiveness of improving adherence and metabolic control. A Journal of the American Diabetes Association. 2013;62(Suppl. 1):A198.
44.
Izquierdo R, Morin PC, Bratt K, Moreau Z, Meyer S, Ploutz-Snyder R, et al. School-centered telemedicine for children with type 1 diabetes mellitus. J Pediatr. 2009;155:374–9.PubMedCrossRef
45.
Ritterband LM, Thorndike FP, Cox DJ, Kovatchev BP, Gonder-Frederick LA. A behavior change model for internet interventions. Ann Behav Med. 2009;38:18–27. PMCID:PMC2878721.PubMedCrossRef
46.
Eysenbach G. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13:e126. PMCID:PMC3278112.PubMedCrossRef
47.
Hanauer DA, Wentzell K, Laffel N, Laffel LM. Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS call phone text messaging reminders to support diabetes management. Diabetes Technol Ther. 2009;11:99–106.PubMedCrossRef
48.
Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med. 2006;23:1332–8.PubMedCrossRef
49.
Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28:455–63.PubMedCrossRef
50.
Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34:533–9. PMCID:PMC3041176.PubMedCrossRef
51.
Garcia E, Martin C, Garcia A, Harrison R, Flood D. Systematic analysis of mobile diabetes management applications on different platforms. Lect Notes Comput Sci. 2011;7058:379–96.CrossRef
52.
Demidowich AP, Lu K, Tamler R, Bloomgarden Z. An evaluation of diabetes self-management applications for Android smartphones. J Telemed Telecare. 2012;18:235–8.PubMedCrossRef
53.
Kumar VS, Wentzell KJ, Mikkelsen T, Pentland A, Laffel LM. The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes. Diabetes Technol Ther. 2004;6:445–53.PubMedCrossRef
54.
Klingensmith GJ, Aisenberg J, Kaufman F, Halvorson M, Cruz E, Riordan ME, Varma C, Pardo S, Viggiani MT, Wallace JF, et al. Evaluation of a combined blood glucose monitoring and gaming system (Didget®) for motivation in children, adolescents, and young adults with type 1 diabetes. Pediatr Diabetes. 2011;14(5):350–7.
55.
Nagelberg N, Shemesh Iron M. Classmate — unique edutainment software for better management of diabetes in children. ATTD Presentation. 2013.
Metadaten
Titel
Technology to Optimize Pediatric Diabetes Management and Outcomes
verfasst von
Jessica T. Markowitz
Kara R. Harrington
Lori M. B. Laffel
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 6/2013
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-013-0419-3

Weitere Artikel der Ausgabe 6/2013

Current Diabetes Reports 6/2013 Zur Ausgabe

Psychosocial Aspects (KK Hood, Section Editor)

Positive Psychological Characteristics in Diabetes: A Review

Diabetes Epidemiology (SH Golden, Section Editor)

The Emerging Global Epidemic of Type 1 Diabetes

Psychosocial Aspects (KK Hood, Section Editor)

Psychological Care in a National Health Service: Challenges for People with Diabetes

Diabetes Epidemiology (SH Golden, Section Editor)

Epidemiology of Diabetes and Diabetes Complications in the Elderly: An Emerging Public Health Burden

Psychosocial Aspects (KK Hood, Section Editor)

The Challenges and Future Considerations Regarding Pregnancy-Related Outcomes in Women with Pre-Existing Diabetes

Diabetes Epidemiology (SH Golden, Section Editor)

The Growing Prevalence of Type 2 Diabetes: Increased Incidence or Improved Survival?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise